Valsartan

|| Ir a Portada de Enciclopedia


Valsartan / Valsartan

Volver a Valsartan

Bibliografia en Core Clinical Journals

 



Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial.
Circulation. 2013 Jan 22; 127(3): 322-30. van der Bom, Teun; Winter, Michiel M; Bouma, Berto J; Groenink, Maarten; Vliegen, Hubert W; Pieper, Petronella G; van Dijk, Arie P J; Sieswerda, Gertjan T; Roos-Hesselink, Jolien W; Zwinderman, Aeilko H; Mulder, Barbara J M;

Effect of nateglinide on the incidence of diabetes and cardiovascular events.
The New England journal of medicine. 2010 Apr 22; 362(16): 1463-76. Holman, Rury R; Haffner, Steven M; McMurray, John J; Bethel, M Angelyn; Holzhauer, Bjorn; Hua, Tsushung A; Belenkov, Yuri; Boolell, Mitradev; Buse, John B; Buckley, Brendan M; Chacra, Antonio R; Chiang, Fu-Tien; Charbonnel, Bernard; Chow, Chun-Chung; Davies, Melanie J; Deedwania, Prakash; Diem, Peter; Einhorn, Daniel; Fonseca, Vivian; Fulcher, Gregory R; Gaciong, Zbigniew; Gaztambide, Sonia; Giles, Thomas; Horton, Edward; Ilkova, Hasan; Jenssen, Trond; Kahn, Steven E; Krum, Henry; Laakso, Markku; Leiter, Lawrence A; Levitt, Naomi S; Mareev, Viacheslav; Martinez, Felipe; Masson, Chantal; Mazzone, Theodore; Meaney, Eduardo; Nesto, Richard; Pan, Changyu; Prager, Rudolf; Raptis, Sotirios A; Rutten, Guy E H M; Sandstroem, Herbert; Schaper, Frank; Scheen, Andre; Schmitz, Ole; Sinay, Isaac; Soska, Vladimir; Stender, Steen; Tamas, Gyula; Tognoni, Gianni; Tuomilehto, Jaako; Villamil, Alberto S; Vozar, Juraj; Califf, Robert M;

Cardio-cerebrovascular protective effects of valsartan in high-risk hypertensive patients with coronary artery disease (from the Kyoto Heart Study).
The American journal of cardiology. 2012 May 1; 109(9): 1308-14. Shiraishi, Jun; Sawada, Takahisa; Koide, Masahiro; Yamada, Hiroyuki; Matsubara, Hiroaki;

Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea.
American journal of respiratory and critical care medicine. 2010 Oct 1; 182(7): 954-60. Pepin, Jean-Louis; Tamisier, Renaud; Barone-Rochette, Gilles; Launois, Sandrine H; Levy, Patrick; Baguet, Jean-Philippe;

Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.
American heart journal. 2010 May; 159(5): 857-63. Disertori, Marcello; Lombardi, Federico; Barlera, Simona; Latini, Roberto; Maggioni, Aldo P; Zeni, Prisca; Di Pasquale, Giuseppe; Cosmi, Franco; Franzosi, Maria Grazia;

Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.
Diabetes. 2013 Oct; 62(10): 3547-52. Koh, Kwang Kon; Lim, Soo; Choi, Hanul; Lee, Yonghee; Han, Seung Hwan; Lee, Kyounghoon; Oh, Pyung Chun; Sakuma, Ichiro; Shin, Eak Kyun; Quon, Michael J;

Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricle.
Am Heart J. 2010 Nov;160(5):812-8. doi: 10.1016/j.ahj.2010.08.005. van , Winter M.M., Bouma B.J., Groenink M., Vliegen H.W., Pieper P.G., van D., Sieswerda G.T., Roos-Hesslink J.W., Zwinderman A.H., Mulder B.J.

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study.
Lancet. 2010 Apr 10; 375(9722): 1255-66. Ruilope, Luis Miguel; Dukat, Andrej; Bohm, Michael; Lacourciere, Yves; Gong, Jianjian; Lefkowitz, Martin P;

The effects of long-term valsartan treatment on skeletal muscle fatty acid handling in humans with impaired glucose metabolism.
The Journal of clinical endocrinology and metabolism. 2013 May; 98(5): E891-6. Moors, Chantalle C M; Blaak, Ellen E; van der Zijl, Nynke J; Diamant, Michaela; Goossens, Gijs H;

Impact of angiotensin II receptor blocker therapy (olmesartan or valsartan) on coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable angina pectoris.
The American journal of cardiology. 2013 Aug 1; 112(3): 363-8. Ishii, Hideki; Kobayashi, Masakazu; Kurebayashi, Nobutake; Yoshikawa, Daiji; Suzuki, Susumu; Ichimiya, Satoshi; Kanashiro, Masaaki; Sone, Takahito; Tsuboi, Hideyuki; Amano, Tetsuya; Uetani, Tadayuki; Harada, Ken; Marui, Nobuyuki; Murohara, Toyoaki;

Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients.
Heart (British Cardiac Society). 2011 Sep; 97(17): 1425-32. Hong, Soon Jun; Choi, Seung Cheol; Ahn, Chul Min; Park, Jae Hyung; Kim, Jae Sang; Lim, Do-Sun;

Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans.
Clinical pharmacology and therapeutics. 2010 Jun; 87(6): 686-92. Kuster, G M; Nietlispach, F; Kiowski, W; Schindler, R; Bernheim, A; Schuetz, P; Mueller, B; Morgenthaler, N G; Ruter, F; Riesen, W; Rickli, H; Brunner-La Rocca, H P;

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Lancet. 2012 Oct 20; 380(9851): 1387-95. Solomon, Scott D; Zile, Michael; Pieske, Burkert; Voors, Adriaan; Shah, Amil; Kraigher-Krainer, Elisabeth; Shi, Victor; Bransford, Toni; Takeuchi, Madoka; Gong, Jianjian; Lefkowitz, Martin; Packer, Milton; McMurray, John J V;

Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.
American heart journal. 2011 Aug; 162(2): 382-9. Disertori, Marcello; Lombardi, Federico; Barlera, Simona; Maggioni, Aldo Pietro; Favero, Chiara; Franzosi, Maria Grazia; Lucci, Donata; Staszewsky, Lidia; Fabbri, Gianna; Quintarelli, Silvia; Bianconi, Leopoldo; Latini, Roberto;

Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).
American heart journal. 2010 Jul; 160(1): 145-51. Shamshad, Faisal; Kenchaiah, Satish; Finn, Peter V; Soler-Soler, Jordi; McMurray, John J V; Velazquez, Eric J; Maggioni, Aldo P; Califf, Robert M; Swedberg, Karl; Kober, Lars; Belenkov, Yuri; Varshavsky, Sergei; Pfeffer, Marc A; Solomon, Scott D;

Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
J Am Coll Cardiol. 2014 Feb 11;63(5):447-56. doi: 10.1016/j.jacc.2013.09.052. Epub 2013 Oct 30. Kraigher-Krainer E., Shah A.M., Gupta D.K., Santos A., Claggett B., Pieske B., Zile M.R., Voors A.A., Lefkowitz M.P., Packer M., McMurray J.J., Solomon S.D.

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
Am Heart J. 2013 Nov;166(5):935-40.e1. doi: 10.1016/j.ahj.2013.08.012. Epub 2013 Oct 7. Latini R., Staszewsky L., Sun J.L., Bethel M.A., Disertori M., Haffner S.M., Holman R.R., Chang F., Giles T.D., Maggioni A.P., Rutten G.E., Standl E., Thomas L., Tognoni G., Califf R.M., McMurray J.J.

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.
BMJ (Clinical research ed.). 2011; 343d4366. Slagman, Maartje C J; Waanders, Femke; Hemmelder, Marc H; Woittiez, Arend-Jan; Janssen, Wilbert M T; Lambers Heerspink, Hiddo J; Navis, Gerjan; Laverman, Gozewijn D;

Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
Circulation. 2010 Oct 5; 122(14): 1387-95. Anand, Inder S; Kempf, Tibor; Rector, Thomas S; Tapken, Heike; Allhoff, Tim; Jantzen, Franziska; Kuskowski, Michael; Cohn, Jay N; Drexler, Helmut; Wollert, Kai C;

Effect of valsartan on the incidence of diabetes and cardiovascular events.
The New England journal of medicine. 2010 Apr 22; 362(16): 1477-90. McMurray, John J; Holman, Rury R; Haffner, Steven M; Bethel, M Angelyn; Holzhauer, Bjorn; Hua, Tsushung A; Belenkov, Yuri; Boolell, Mitradev; Buse, John B; Buckley, Brendan M; Chacra, Antonio R; Chiang, Fu-Tien; Charbonnel, Bernard; Chow, Chun-Chung; Davies, Melanie J; Deedwania, Prakash; Diem, Peter; Einhorn, Daniel; Fonseca, Vivian; Fulcher, Gregory R; Gaciong, Zbigniew; Gaztambide, Sonia; Giles, Thomas; Horton, Edward; Ilkova, Hasan; Jenssen, Trond; Kahn, Steven E; Krum, Henry; Laakso, Markku; Leiter, Lawrence A; Levitt, Naomi S; Mareev, Viacheslav; Martinez, Felipe; Masson, Chantal; Mazzone, Theodore; Meaney, Eduardo; Nesto, Richard; Pan, Changyu; Prager, Rudolf; Raptis, Sotirios A; Rutten, Guy E H M; Sandstroem, Herbert; Schaper, Frank; Scheen, Andre; Schmitz, Ole; Sinay, Isaac; Soska, Vladimir; Stender, Steen; Tamas, Gyula; Tognoni, Gianni; Tuomilehto, Jaako; Villamil, Alberto S; Vozar, Juraj; Califf, Robert M;


Subir